Zobrazeno 1 - 10
of 248
pro vyhledávání: '"Mary R Schwartz"'
Publikováno v:
Human Pathology Reports, Vol 29, Iss , Pp 300658- (2022)
We report a 38-year-old female with a history of primary pelvic PEComa and subsequent metastatic PEComa to the mediastinum who presented with recurrent mediastinal metastasis in April 2021. At initial presentation in 2010, the patient reported a thre
Externí odkaz:
https://doaj.org/article/12fc8eab4ce7455fbd8a5b9b98dcab59
Publikováno v:
Cardio-Oncology, Vol 7, Iss 1, Pp 1-9 (2021)
Abstract Background Cardiac metastasis due to colon cancer is extraordinarily uncommon. Given the rarity of diagnosis, there is paucity of evidence and hence, no established guidelines for evaluation or clinical management strategy. Clinical presenta
Externí odkaz:
https://doaj.org/article/5a691fad44f642489b8c29137c3ee15e
Autor:
Shaden Khalaf, MD, Mohammad Hussain, MD, Melina Awar, MD, Hector A. Preti, MD, Mary R. Schwartz, MD, Miguel Valderrabano, MD, Faisal Nabi, MD, Dipan Shah, MD
Publikováno v:
JACC: Case Reports, Vol 1, Iss 4, Pp 638-642 (2019)
A 58-year-old male patient with incessant ventricular tachycardia was referred to cardiac magnetic resonance for scar assessment. He was found to have metastatic amelanotic melanoma of the heart. The cardiac magnetic resonance–based diagnosis of ca
Externí odkaz:
https://doaj.org/article/36f564a5e4804776a99746e8787ed3d6
Publikováno v:
Human Pathology: Case Reports, Vol 24, Iss , Pp 200488- (2021)
Background: Rosai-Dorfman disease (RDD) is a rare entity characterized by lymphadenopathy with dilated lymph node sinuses containing lymphocytes, plasma cells, and histiocytes exhibiting emperipolesis. IgG4-related disease (IgG4-RD) is relatively mor
Externí odkaz:
https://doaj.org/article/10c0475f9f784e8ababd4d0ff1ce00bb
Autor:
Tejal A. Patel, Joe E. Ensor, Sarah L. Creamer, Toniva Boone, Angel A. Rodriguez, Poly A. Niravath, Jorge G. Darcourt, Jane L. Meisel, Xiaoxian Li, Jing Zhao, John G. Kuhn, Roberto R. Rosato, Wei Qian, Anna Belcheva, Mary R. Schwartz, Virginia G. Kaklamani, Jenny C. Chang
Publikováno v:
Breast Cancer Research, Vol 21, Iss 1, Pp 1-9 (2019)
Abstract Background Neoadjuvant dual human epidermal growth factor receptor (HER2) blockade with trastuzumab and pertuzumab plus paclitaxel leads to an overall pathologic complete response (pCR) rate of 46%. Dual HER2 blockade with ado-trastuzumab em
Externí odkaz:
https://doaj.org/article/4491401233a240d9afeec8c1bf909d3d
Autor:
Neil, Chevli, Waqar, Haque, Kevin T, Tran, Andrew M, Farach, Mary R, Schwartz, Sandra S, Hatch, E Brian, Butler, Bin S, Teh
Publikováno v:
Practical Radiation Oncology. 13:e230-e238
The 21-gene RT-PCR recurrence score (RS) is performed in patients with hormone receptor-positive (ER+, PR+), human epidermal growth factor receptor 2 (HER2)-negative, N0 breast cancer to determine which patients will likely benefit from chemotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9d97ea666db0b1309ebf0515335fa15
https://doi.org/10.1016/j.prro.2022.08.004
https://doi.org/10.1016/j.prro.2022.08.004
Autor:
Paloma del C. Monroig-Bosque MD, PhD, Jim W. Hsu MD, PhD, Michelle S. Lin MD, Ahmed N. Shehabeldin MD, John T. Rogers MD, Charlotte F. Kim MD, Ayaz G. Kalsekar MD, Zhicheng Jin PhD, Lukas R. Cara MD, Andreia N. Barbieri MD, Ziad El-Zaatari MD, Ghazaleh Eskandari MD, Tiffany G. Sheu MD, Jessica A. Tomsula MD, Scott W. Long MD, PhD, Arthur W. Zieske MD, Christopher M. Leveque MD, Eric Salazar MD, PhD, Dina R. Mody MD, Mary R. Schwartz MD, Matthew D. Cykowski MD, Xin Yi PhD, Suzanne Z. Powell MD, Jessica S. Thomas MD, PhD, MPH
Publikováno v:
Academic Pathology, Vol 7 (2020)
Pathology training programs throughout the United States have endured unprecedented challenges dealing with the ongoing coronavirus disease 2019 pandemic. At Houston Methodist Hospital, the Department of Pathology and Genomic Medicine planned and exe
Externí odkaz:
https://doaj.org/article/6c1e04ccfc5e4acebebc413f17bab497
Autor:
Amanda B. Moyer, MD, Daniel J. Duhon, MD, Mary R. Schwartz, MD, Jae Y. Ro, MD PhD, Ross A. Miller, MD
Publikováno v:
Human Pathology: Case Reports, Vol 12, Iss C, Pp 32-35 (2018)
Clear cell hidradenoma (CCH) is an uncommon benign dermal-based tumor that typically presents on the head, neck, and upper extremities as a solitary firm nodule. The clear cytoplasm can resemble benign and malignant clear cell neoplasms from multiple
Externí odkaz:
https://doaj.org/article/bf44fefdfb6641a88d5ee4a5f79b334c
Autor:
Neil, Chevli, Waqar, Haque, Kevin T, Tran, Andrew M, Farach, Mary R, Schwartz, Sandra S, Hatch, E Brian, Butler, Bin S, Teh
Publikováno v:
Radiotherapy and Oncology. 174:37-43
Based on the results of the Cancer and Leukemia Group B (CALGB) 9343 trial, patients age ≥70 with T1N0 hormone receptor positive (ER/PR+), human epidermal growth factor receptor-2 negative (HER2-) breast cancer who are treated with breast conservin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaacbf58d838aeaab25a146a618dfa66
https://doi.org/10.1016/j.radonc.2022.06.013
https://doi.org/10.1016/j.radonc.2022.06.013
Autor:
Waqar Mohammad Haque, Vivek Verma, Niva Mangalampalli, E. Brian Butler, Kai Sun, Dharamvir Jain, Candy Arentz, Bin S Teh, Mary R Schwartz
BACKGROUND The 21-gene assay (Oncotype DX®) can be used to guide use of chemotherapy in the management of patients with pN1 [1–3 positive lymph nodes (LNs)] breast cancer, specifically with respect to assessing potential benefit of chemotherapy. H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4eebfaef1ca7a3f23f7ae6fea7093a00
https://doi.org/10.21203/rs.3.rs-2793687/v1
https://doi.org/10.21203/rs.3.rs-2793687/v1
